Showing results (251-260 of 259) with videos related to

Sort By:
Pageof 26
You have reached the last page of results.This site can display upto 259 results.
ACS Medicinal Chemistry Letters|October 16, 2020
Discovery of Selective, Covalent FGFR4 Inhibitors with Antitumor Activity in Models of Hepatocellular CarcinomaHaibo Liu, Deqiang Niu, Robert Tjin Tham Sjin, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 1, 2024
Visual reading for [<sup>18</sup>F]Florzolotau Tau PET scans in progressive supranuclear palsyFeng-Tao Liu, Jia-Ying Lu, Xin-Yi Li, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 8, 2023
<sup>18</sup> F-Florzolotau Positron Emission Tomography Imaging of Tau Pathology in the Living Brains of Patients with Corticobasal SyndromeFeng-Tao Liu, Jia-Ying Lu, Xin-Yi Li, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 8, 2024
Incremental value of amyloid PET in a tertiary memory clinic setting in ChinaKe-Liang Chen, Ming-Yu Wang, Jie Wu, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 9, 2006
Development of 17-allylamino-17-demethoxygeldanamycin hydroquinone hydrochloride (IPI-504), an anti-cancer agent directed against Hsp90Jens R Sydor, Emmanuel Normant, Christine S Pien, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|November 18, 2024
<sup>18</sup>F-Florzolotau PET Imaging Unveils Tau Pathology in Dementia with Lewy BodiesGan Tang, Jia-Ying Lu, Xin-Yi Li, et al.
Frontiers in Immunology|November 6, 2024
Evaluation of STK17B as a cancer immunotherapy target utilizing highly potent and selective small molecule inhibitorsFelix Scheuplein, Florian Renner, John E Campbell, et al.
Forestry Research|May 25, 2026
Spatiotemporal genomic patterns of <i>Quercus gilva</i>: decoupling historical isolation from contemporary environmental adaptationShan-Shan Wang, Tian-Rui Wang, Ling-Ling Wang, et al.
Cancer Cell|October 3, 2025
Neoadjuvant treatment of IBI310 plus sintilimab in locally advanced MSI-H/dMMR colon cancer: A randomized phase 1b studyFeng Wang, Gong Chen, Meng Qiu, et al.
Pageof 26